Oncologie
Gestion de la thrombocytopénie
Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (manokatra rohy)
Loharanon-kevitra: Br J Haematol 2013;161(5):738-40.
Rakitra: PubMed 23480574
DOI: 10.1111/bjh.12284
https://www.ncbi.nlm.nih.gov/pubmed/23480574 (manokatra rohy)
A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. (manokatra rohy)
Loharanon-kevitra: Haematologica 2021;106(4):1148-57.
Rakitra: PubMed 32499239
DOI: 10.3324/haematol.2020.251900
https://www.ncbi.nlm.nih.gov/pubmed/32499239 (manokatra rohy)
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia. (manokatra rohy)
Loharanon-kevitra: Cancer 2008;113(6):1338-43.
Rakitra: PubMed 18629842
DOI: 10.1002/cncr.23718
https://www.ncbi.nlm.nih.gov/pubmed/18629842 (manokatra rohy)
Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia. (manokatra rohy)
Loharanon-kevitra: Transfusion 2012;52(4):739-41.
Rakitra: PubMed 22082044
DOI: 10.1111/j.1537-2995.2011.03382.x
https://www.ncbi.nlm.nih.gov/pubmed/22082044 (manokatra rohy)
The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (manokatra rohy)
Loharanon-kevitra: Leuk Lymphoma 2007;48(1):9-15.
Rakitra: PubMed 17325843
DOI: 10.1080/10428190600909115
https://www.ncbi.nlm.nih.gov/pubmed/17325843 (manokatra rohy)
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide. (manokatra rohy)
Loharanon-kevitra: BMC Cancer 2013;13:121.
Rakitra: PubMed 23497336
DOI: 10.1186/1471-2407-13-121
https://www.ncbi.nlm.nih.gov/pubmed/23497336 (manokatra rohy)
Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma. (manokatra rohy)
Loharanon-kevitra: Pathol Oncol Res 2011;17(1):141-3.
Rakitra: PubMed 20628840
DOI: 10.1007/s12253-010-9276-4
https://www.ncbi.nlm.nih.gov/pubmed/20628840 (manokatra rohy)
Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient. (manokatra rohy)
Loharanon-kevitra: J Neurooncol 2012;106(2):427-9.
Rakitra: PubMed 21833801
DOI: 10.1007/s11060-011-0675-5
https://www.ncbi.nlm.nih.gov/pubmed/21833801 (manokatra rohy)
Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (manokatra rohy)
Loharanon-kevitra: Lancet 2003;361(9354):275-80.
Rakitra: PubMed 12559860
https://www.ncbi.nlm.nih.gov/pubmed/12559860 (manokatra rohy)
Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (manokatra rohy)
Loharanon-kevitra: J Clin Oncol 2015;33(15):1674-9.
Rakitra: PubMed 25870085
DOI: 10.1200/JCO.2014.57.9912
https://www.ncbi.nlm.nih.gov/pubmed/25870085 (manokatra rohy)
Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors. (manokatra rohy)
Loharanon-kevitra: Platelets. 2022 3;33(7):1024-1030.
Rakitra: PubMed 35040375
DOI: 10.1080/09537104.2022.2026910
Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. (manokatra rohy)
Loharanon-kevitra: Cancer 2014;120(12):1838-46.
Rakitra: PubMed 24706489
DOI: 10.1002/cncr.28663
https://www.ncbi.nlm.nih.gov/pubmed/24706489 (manokatra rohy)
A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine. (manokatra rohy)
Loharanon-kevitra: Leuk Lymphoma 2013;54(2):321-8.
Rakitra: PubMed 22906162
DOI: 10.3109/10428194.2012.713477
https://www.ncbi.nlm.nih.gov/pubmed/22906162 (manokatra rohy)
Thrombopoietin-receptor agonists in haematological disorders: the Danish experience. (manokatra rohy)
Loharanon-kevitra: Platelets 2012;23(6):423-9.
Rakitra: PubMed 22185370
DOI: 10.3109/09537104.2011.634931
https://www.ncbi.nlm.nih.gov/pubmed/22185370 (manokatra rohy)
Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial. (manokatra rohy)
Loharanon-kevitra: Ann Hematol 2015;94(1):117-28.
Rakitra: PubMed 25069650
DOI: 10.1007/s00277-014-2158-1
https://www.ncbi.nlm.nih.gov/pubmed/25069650 (manokatra rohy)
The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma. (manokatra rohy)
Loharanon-kevitra: J Hematol Oncol 2015;8:37.
Rakitra: PubMed 25886818
DOI: 10.1186/s13045-015-0136-2
https://www.ncbi.nlm.nih.gov/pubmed/25886818 (manokatra rohy)
Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. (manokatra rohy)
Loharanon-kevitra: J Clin Oncol 2010;28(3):437-44.
Rakitra: PubMed 20008626
DOI: 10.1200/JCO.2009.24.7999
https://www.ncbi.nlm.nih.gov/pubmed/20008626 (manokatra rohy)
The use of simple patient blood management strategies as an alternative to platelet and red cell transfusion in autologous stem cell transplant. (manokatra rohy)
Loharanon-kevitra: Blood 2013;122(21):2140.
https://www.bloodjournal.org/content/122/21/2140 (manokatra rohy)
The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. (manokatra rohy)
Loharanon-kevitra: Blood 1999;93(10):3286-93.
Rakitra: PubMed 10233880
https://www.ncbi.nlm.nih.gov/pubmed/10233880 (manokatra rohy)
A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia. (manokatra rohy)
Loharanon-kevitra: Am J Hematol 2018;93(4):E86-E88.
Rakitra: PubMed 29274130
DOI: 10.1002/ajh.25022
https://www.ncbi.nlm.nih.gov/pubmed/29274130 (manokatra rohy)
Pharmacological therapies to minimise platelet transfusion. (manokatra rohy)
Loharanon-kevitra: Transfus Sci 2000;22(3):149-53.
Rakitra: PubMed 10831916
https://www.ncbi.nlm.nih.gov/pubmed/10831916 (manokatra rohy)
Romiplostim for management of chemotherapy-induced thrombocytopenia. (manokatra rohy)
Loharanon-kevitra: Support Care Cancer 2014;22(5):1217-22.
Rakitra: PubMed 24414994
DOI: 10.1007/s00520-013-2074-2
https://www.ncbi.nlm.nih.gov/pubmed/24414994 (manokatra rohy)
Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders. (manokatra rohy)
Loharanon-kevitra: Expert Opin Drug Metab Toxicol 2013;9(12):1667-75.
Rakitra: PubMed 24215532
DOI: 10.1517/17425255.2013.858119
https://www.ncbi.nlm.nih.gov/pubmed/24215532 (manokatra rohy)
High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (manokatra rohy)
Loharanon-kevitra: Leuk Lymphoma. 2019;60(9):2324-7.
Rakitra: PubMed 30773115
DOI: 10.1080/10428194.2019.1577414
https://www.ncbi.nlm.nih.gov/pubmed/30773115 (manokatra rohy)
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial. (manokatra rohy)
Loharanon-kevitra: Lancet Haematol 2015;2(10):e417-26.
Rakitra: PubMed 26686043
https://www.ncbi.nlm.nih.gov/pubmed/26686043 (manokatra rohy)
Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. (manokatra rohy)
Loharanon-kevitra: Am J Blood Res 2013;3(3):260-4.
Rakitra: PubMed 23997988
https://www.ncbi.nlm.nih.gov/pubmed/23997988 (manokatra rohy)
Safety and efficacy of eltrombopag in post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia. (manokatra rohy)
Loharanon-kevitra: Indian J Hematol Blood Transfus 2015;31(4):413-5.
Rakitra: PubMed 26306064
DOI: 10.1007/s12288-014-0491-0
https://www.ncbi.nlm.nih.gov/pubmed/26306064 (manokatra rohy)
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. (manokatra rohy)
Loharanon-kevitra: Blood 2010;116(12):2127-33.
Rakitra: PubMed 20530792
DOI: 10.1182/blood-2010-03-276691
https://www.ncbi.nlm.nih.gov/pubmed/20530792 (manokatra rohy)
Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. (manokatra rohy)
Loharanon-kevitra: Blood 2012;120(2):386-94.
Rakitra: PubMed 22627766
DOI: 10.1182/blood-2011-12-399667
https://www.ncbi.nlm.nih.gov/pubmed/22627766 (manokatra rohy)
Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. (manokatra rohy)
Loharanon-kevitra: Cancer 2011;117(5):992-1000.
Rakitra: PubMed 20945323
DOI: 10.1002/cncr.25545
https://www.ncbi.nlm.nih.gov/pubmed/20945323 (manokatra rohy)
Romiplostim treatment of chemotherapy-induced thrombocytopenia. (manokatra rohy)
Loharanon-kevitra: J Clin Oncol 2019;37(31):2892-8.
Rakitra: PubMed 31545663
DOI: 10.1200/JCO.18.01931
https://www.ncbi.nlm.nih.gov/pubmed/31545663 (manokatra rohy)
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. (manokatra rohy)
Loharanon-kevitra: Blood 2000;95(9):2983-9.
Rakitra: PubMed 10779449
https://www.ncbi.nlm.nih.gov/pubmed/10779449 (manokatra rohy)
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine. (manokatra rohy)
Loharanon-kevitra: Eur J Haematol 2014;93(5):439-45.
Rakitra: PubMed 24853277
DOI: 10.1111/ejh.12383
https://www.ncbi.nlm.nih.gov/pubmed/24853277 (manokatra rohy)
Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation. (manokatra rohy)
Loharanon-kevitra: Biol Blood Marrow Transplant 2016;22(5):919-24.
Rakitra: PubMed 26785333
DOI: 10.1016/j.bbmt.2016.01.018
https://www.ncbi.nlm.nih.gov/pubmed/26785333 (manokatra rohy)
Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (manokatra rohy)
Loharanon-kevitra: Ann Oncol 2005;16(1):139-45.
Rakitra: PubMed 15598951
DOI: 10.1093/annonc/mdi007
https://www.ncbi.nlm.nih.gov/pubmed/15598951 (manokatra rohy)
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. (manokatra rohy)
Loharanon-kevitra: J Hematol Oncol 2012;5:71.
Rakitra: PubMed 23190430
DOI: 10.1186/1756-8722-5-71
https://www.ncbi.nlm.nih.gov/pubmed/23190430 (manokatra rohy)
Romiplostim for chemotherapy-induced thrombocytopenia: efficacy and safety of extended use. (manokatra rohy)
Loharanon-kevitra: Res Pract Thromb Haemost. 2022;6(3):e12701.
Rakitra: PubMed 35582038
DOI: 10.1002/rth2.12701
Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. (manokatra rohy)
Loharanon-kevitra: Blood 2009;114(18):3899-908.
Rakitra: PubMed 19710504
DOI: 10.1182/blood-2009-04-219493
https://www.ncbi.nlm.nih.gov/pubmed/19710504 (manokatra rohy)